Genetics and celiac disease: the importance of screening

References

• Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357(17):1731-43
   PubMed Web of Science ®Google Scholar
• Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119(1):234-42
   PubMed Web of Science ®Google Scholar
• Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163(3):286-92
   PubMed Web of Science ®Google Scholar
• Green PH, Jabri B. Coeliac disease. Lancet 2003;362(9381):383-91
   PubMed Web of Science ®Google Scholar
• Dube C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005;128(4 Suppl 1):S57-67
   PubMed Web of Science ®Google Scholar
• Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Alimentary pharmacology & therapeutics 2007;26(9):1217-25
   PubMed Web of Science ®Google Scholar
• Catassi C, Kryszak D, Bhatti B, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med 2010;42(7):530-8
   PubMed Web of Science ®Google Scholar
• Maki M, Kallonen K, Lahdeaho ML, Visakorpi JK. Changing pattern of childhood coeliac disease in Finland. Acta Paediatr Scand 1988;77(3):408-12
   PubMed Web of Science ®Google Scholar
• Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006;131(6):1981-2002
   PubMed Web of Science ®Google Scholar
• Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005;40(1):1-19
   PubMed Web of Science ®Google Scholar
• Rostom A, Dube C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005;128(4 Suppl 1):S38-46
   PubMed Web of Science ®Google Scholar
• Mozo L, Gomez J, Escanlar E, et al. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients. J Pediatr Gastroenterol Nutr 2012;55(1):50-5
   PubMed Web of Science ®Google Scholar
• Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54(1):136-60
   PubMed Web of Science ®Google Scholar
• National Institutes of Health Consensus Development Conference Statement on Celiac Disease. June 28-30 2004;Gastroenterology 2005;128(4 Suppl 1):S1-9
   Google Scholar
• Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med 2010;123(8):691-3
   PubMed Web of Science ®Google Scholar
• Abrams JA, Diamond B, Rotterdam H, Green PH. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci 2004;49(4):546-50
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009;137(1):88-93
   PubMed Web of Science ®Google Scholar
• Gomez JC, Selvaggio G, Pizarro B, et al. Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study. Am J Gastroenterol 2002;97(11):2785-90
   PubMed Web of Science ®Google Scholar
• Dorn SD, Matchar DB. Cost-effectiveness analysis of strategies for diagnosing celiac disease. Dig Dis Sci 2008;53(3):680-8
   PubMed Web of Science ®Google Scholar
• Green PH, Neugut AI, Naiyer AJ, et al. Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States. Journal of insurance medicine 2008;40(3-4):218-28
   PubMedGoogle Scholar
• Hogberg L, Falth-Magnusson K, Grodzinsky E, Stenhammar L. Familial prevalence of coeliac disease: a twenty-year follow-up study. Scand J Gastroenterol 2003;38(1):61-5
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Van Dyke CT, Lahr BD, et al. Predictors of family risk for celiac disease: a population-based study. Clini Gastroenterol Hepatol 2008;6(9):983-7
   PubMed Web of Science ®Google Scholar
• Greco L, Romino R, Coto I, et al. The first large population based twin study of coeliac disease. Gut 2002;50(5):624-8
   PubMed Web of Science ®Google Scholar
• Nistico L, Fagnani C, Coto I, et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 2006;55(6):803-8
   PubMed Web of Science ®Google Scholar
• Book L, Zone JJ, Neuhausen SL. Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families. Am J Gastroenterol 2003;98(2):377-81
   PubMed Web of Science ®Google Scholar
• Bevan S, Popat S, Braegger CP, et al. Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet 1999;36(9):687-90
   PubMed Web of Science ®Google Scholar
• Sollid LM, Markussen G, Ek J, et al. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169(1):345-50
   PubMed Web of Science ®Google Scholar
• Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clinical Gastroenterol Hepatol 2005;3(9):843-51
   PubMed Web of Science ®Google Scholar
• Mazzilli MC, Ferrante P, Mariani P, et al. A study of Italian pediatric celiac disease patients confirms that the primary HLA association is to the DQ(alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol 1992;33(2):133-9
   PubMed Web of Science ®Google Scholar
• Doherty DG, Vaughan RW, Donaldson PT, Mowat AP. HLA DQA, DQB, and DRB genotyping by oligonucleotide analysis: distribution of alleles and haplotypes in British caucasoids. Hum Immunol 1992;34(1):53-63
   PubMed Web of Science ®Google Scholar
• Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003;61(2):105-17
   PubMedGoogle Scholar
• Liu E, Rewers M, Eisenbarth GS. Genetic testing: who should do the testing and what is the role of genetic testing in the setting of celiac disease? Gastroenterology 2005;128(4 Suppl 1):S33-7
   PubMed Web of Science ®Google Scholar
• Wolters VM, Wijmenga C. Genetic background of celiac disease and its clinical implications. Am J Gastroenterol 2008;103(1):190-5
   PubMed Web of Science ®Google Scholar
• Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009;137(6):1912-33
   PubMed Web of Science ®Google Scholar
• Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993;105(3):910-22
   PubMed Web of Science ®Google Scholar
• Arentz-Hansen H, Korner R, Molberg O, et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000;191(4):603-12
   PubMed Web of Science ®Google Scholar
• Kim CY, Quarsten H, Bergseng E, et al. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA 2004;101(12)):4175-9
   PubMed Web of Science ®Google Scholar
• Vader W, Stepniak D, Kooy Y, et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 2003;100(21)):12390-5
   PubMed Web of Science ®Google Scholar
• Karinen H, Karkkainen P, Pihlajamaki J, et al. Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease. Scand J Gastroenterol 2006;41(2):191-9
   PubMed Web of Science ®Google Scholar
• Vermeulen BA, Hogen Esch CE, Yuksel Z, et al. Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect. Scand J Gastroenterol 2009;44(1):40-5
   PubMed Web of Science ®Google Scholar
• Johnson TC, Diamond B, Memeo L, et al. Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts. Clin Gastroenterol Hepatol 2004;2(10):888-94
   PubMed Web of Science ®Google Scholar
• Gutierrez-Achury J, Coutinho de Almeida R, Wijmenga C. Shared genetics in coeliac disease and other immune-mediated diseases. J Intern Med 2011;269(6):591-603
   PubMed Web of Science ®Google Scholar
• Fernandez-Cavada-Pollo MJ, Alcala-Pena MI, Vargas-Perez ML, et al. Celiac disease and HLA-DQ genotype: diagnosis of different genetic risk profiles related to the age in Badajoz, southwestern Spain. Rev Esp Enferm Dig 2013;105(8):469-76
   PubMed Web of Science ®Google Scholar
• Schirru E, Jores RD, Cicotto L, et al. High frequency of low-risk human leukocyte antigen class II genotypes in latent celiac disease. Hum Immunol 2011;72(2):179-82
   PubMed Web of Science ®Google Scholar
• Leonetti, et al. Impact of infant feeding pattern and. HLA Alleles on the frequency of Celiac Disease in at-risk infants: Ten Years Results of an Intervention Study.
   Google Scholar
• Liu E, Lee HS, Aronsson CA, et al. Risk of Pediatric Celiac Disease According to HLA Haplotype and Country. N Eng J Med 2014;371(1):42-9
   PubMed Web of Science ®Google Scholar
• Dubois PC, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010;42(4):295-302
   PubMed Web of Science ®Google Scholar
• Hunt KA, Zhernakova A, Turner G, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008;40(4):395-402
   PubMed Web of Science ®Google Scholar
• van Heel DA, Franke L, Hunt KA, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007;39(7):827-9
   PubMed Web of Science ®Google Scholar
• Ahn R, Ding YC, Murray J, et al. Association analysis of the extended MHC region in celiac disease implicates multiple independent susceptibility loci. PLoS One 2012;7(5):e36926
   PubMed Web of Science ®Google Scholar
• Festen EA, Goyette P, Green T, et al. A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn’s disease and celiac disease. PLoS Genet 2011;7(1):e1001283
   PubMed Web of Science ®Google Scholar
• Trynka G, Hunt KA, Bockett NA, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011;43(12):1193-201
   PubMed Web of Science ®Google Scholar
• Zhernakova A, Stahl EA, Trynka G, et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011;7(2):e1002004
   Web of Science ®Google Scholar
• Salvati VM, MacDonald TT, Bajaj-Elliott M, et al. Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease. Gut 2002;50(2):186-90
   PubMed Web of Science ®Google Scholar
• Fasano A. Intestinal zonulin: open sesame!. Gut 2001;49(2):159-62
   PubMed Web of Science ®Google Scholar
• Fasano A. Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol 2008;173(5):1243-52
   PubMed Web of Science ®Google Scholar
• Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev 2011;91(1):151-75
   PubMed Web of Science ®Google Scholar
• Fasano A, Not T, Wang W, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000;355(9214):1518-19
   PubMed Web of Science ®Google Scholar
• Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol 2005;2(9):416-22
   PubMedGoogle Scholar
• Monsuur AJ, de Bakker PI, Alizadeh BZ, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005;37(12):1341-4
   PubMed Web of Science ®Google Scholar
• Papp M, Foldi I, Nemes E, et al. Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations. Clin Chem 2008;54(4):697-704
   PubMed Web of Science ®Google Scholar
• Tripathi A, Lammers KM, Goldblum S, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci USA 2009;106(39):16799-804
   PubMed Web of Science ®Google Scholar
• Wapenaar MC, Monsuur AJ, van Bodegraven AA, et al. Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 2008;57(4):463-7
   PubMed Web of Science ®Google Scholar
• Almeida R, Ricano-Ponce I, Kumar V, et al. Fine mapping of the celiac disease-associated LPP locus reveals a potential functional variant. Hum Mol Genet 2014;23(9):2481-9
   PubMed Web of Science ®Google Scholar
• Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008;359(26):2767-77
   PubMed Web of Science ®Google Scholar
• Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, et al. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 1998;43(2):187-9
   PubMed Web of Science ®Google Scholar
• Abraham G, Tye-Din JA, Bhalala OG, et al. Accurate and robust genomic prediction of celiac disease using statistical learning. PLoS Genet 2014 10(2):e1004137
   Google Scholar
• Romanos J, Rosen A, Kumar V, et al. Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants. Gut 2014;63(3):415-22
   PubMed Web of Science ®Google Scholar